Literature DB >> 31248959

The microbiology of pleural infection in adults: a systematic review.

Maged Hassan1,2,3, Tamsin Cargill4, Elinor Harriss5, Rachelle Asciak4,2, Rachel M Mercer4,2, Eihab O Bedawi4,2, David J McCracken4,2, Ioannis Psallidas4,2, John P Corcoran6, Najib M Rahman4,2,7.   

Abstract

BACKGROUND AND OBJECTIVES: Pleural infection is a major cause of morbidity and mortality among adults. Identification of the offending organism is key to appropriate antimicrobial therapy. It is not known whether the microbiological pattern of pleural infection is variable temporally or geographically. This systematic review aimed to investigate available literature to understand the worldwide pattern of microbiology and the factors that might affect such pattern. DATA SOURCES AND ELIGIBILITY CRITERIA: Ovid MEDLINE and Embase were searched between 2000 and 2018 for publications that reported on the microbiology of pleural infection in adults. Both observational and interventional studies were included. Studies were excluded if the main focus of the report was paediatric population, tuberculous empyema or post-operative empyema. STUDY APPRAISAL AND SYNTHESIS
METHODS: Studies of ≥20 patients with clear reporting of microbial isolates were included. The numbers of isolates of each specific organism/group were collated from the included studies. Besides the overall presentation of data, subgroup analyses by geographical distribution, infection setting (community versus hospital) and time of the report were performed.
RESULTS: From 20 980 reports returned by the initial search, 75 articles reporting on 10 241 patients were included in the data synthesis. The most common organism reported worldwide was Staphylococcus aureus. Geographically, pneumococci and viridans streptococci were the most commonly reported isolates from tropical and temperate regions, respectively. The microbiological pattern was considerably different between community- and hospital-acquired infections, where more Gram-negative and drug-resistant isolates were reported in the hospital-acquired infections. The main limitations of this systematic review were the heterogeneity in the method of reporting of certain bacteria and the predominance of reports from Europe and South East Asia.
CONCLUSIONS: In pleural infection, the geographical location and the setting of infection have considerable bearing on the expected causative organisms. This should be reflected in the choice of empirical antimicrobial treatment.
Copyright ©ERS 2019.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31248959     DOI: 10.1183/13993003.00542-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  15 in total

1.  Negative Pleural Fluid Cultures among Patients with Pleural Effusion in a Tertiary Care Hospital: A Descriptive Cross-sectional Study.

Authors:  Srijana Ranjit; Amit Kumar Singh; Ishu Shrestha; Anu Radha Twayana; Prabha Bhandari; Shisir Siwakoti; Shrijana Singh
Journal:  JNMA J Nepal Med Assoc       Date:  2022-05-05       Impact factor: 0.556

2.  The effect of Cyclic-di-GMP on biofilm formation by Pseudomonas aeruginosa in a novel empyema model.

Authors:  Li Zhang; Jinlong Li; Jinhua Liang; Zhenqiang Zhang; Qingjun Wei; Ke Wang
Journal:  Ann Transl Med       Date:  2020-09

3.  A systematic review of comorbidities and outcomes of adult patients with pleural infection.

Authors:  Tamsin N Cargill; Maged Hassan; John P Corcoran; Elinor Harriss; Rachelle Asciak; Rachel M Mercer; David J McCracken; Eihab O Bedawi; Najib M Rahman
Journal:  Eur Respir J       Date:  2019-10-01       Impact factor: 16.671

Review 4.  Management of Pleural Infection.

Authors:  Anand Sundaralingam; Radhika Banka; Najib M Rahman
Journal:  Pulm Ther       Date:  2020-12-09

5.  Bacteriology, antibiotic resistance and risk stratification of patients with culture-positive, community-acquired pleural infection.

Authors:  Marianthi Iliopoulou; Vasileios Skouras; Zoe Psaroudaki; Magda Makarona; Evangelos Vogiatzakis; Eleni Tsorlini; Eleni Katsifa; Dionisios Spyratos; Dimitra Siopi; Ourania Kotsiou; Stelios Xitsas; Maria Martsoukou; Ioanna Sigala; Ioannis Kalomenidis
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

6.  Identification of Microbiome Etiology Associated With Drug Resistance in Pleural Empyema.

Authors:  Zhaoyan Chen; Hang Cheng; Zhao Cai; Qingjun Wei; Jinlong Li; Jinhua Liang; Wenshu Zhang; Zhijian Yu; Dongjing Liu; Lei Liu; Zhenqiang Zhang; Ke Wang; Liang Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-03-16       Impact factor: 5.293

Review 7.  Diagnostics in Pleural Disease.

Authors:  Anand Sundaralingam; Eihab O Bedawi; Najib M Rahman
Journal:  Diagnostics (Basel)       Date:  2020-12-04

8.  Pyogenic lung abscess in an infectious disease unit: a 20-year retrospective study.

Authors:  Thomas Maitre; Vichita Ok; Ruxandra Calin; Ludovic Lassel; Ana Canestri; Michel Denis; Mohammed Hamidi; Sebastian Tavolaro; Charlotte Verdet; Antoine Parrot; Jacques Cadranel; Gilles Pialoux
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 4.031

9.  Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial.

Authors:  José M Porcel; Lucia Ferreiro; Laura Rumi; Esther Espino-Paisán; Carmen Civit; Marina Pardina; Juan Antonio Schoenenberger-Arnaiz; Luis Valdés; Silvia Bielsa
Journal:  Pleura Peritoneum       Date:  2020-02-26

Review 10.  Recent Insights into the Management of Pleural Infection.

Authors:  Maged Hassan; Shefaly Patel; Ahmed S Sadaka; Eihab O Bedawi; John P Corcoran; José M Porcel
Journal:  Int J Gen Med       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.